Daiwa Securities Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Hold |
160
| – | – | ﹤0.01% | 1234 |
|
|
2025
Q1 | $2K | Hold |
160
| – | – | ﹤0.01% | 1202 |
|
|
2024
Q4 | $2K | Hold |
160
| – | – | ﹤0.01% | 1236 |
|
|
2024
Q3 | $2K | Buy |
160
+112
| +233% | +$1.4K | ﹤0.01% | 1237 |
|
|
2024
Q2 | $1K | Hold |
48
| – | – | ﹤0.01% | 1293 |
|
|
2024
Q1 | $1K | Hold |
48
| – | – | ﹤0.01% | 1300 |
|
|
2023
Q4 | $1K | Hold |
48
| – | – | ﹤0.01% | 1299 |
|
|
2023
Q3 | $1K | Hold |
48
| – | – | ﹤0.01% | 1272 |
|
|
2023
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 1340 |
|
|
2023
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 1311 |
|
|
2022
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 1382 |
|
|
2022
Q3 | $0 | Hold |
48
| – | – | ﹤0.01% | 1391 |
|
|
2022
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 1417 |
|
|
2022
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 1410 |
|
|
2021
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 1439 |
|
|
2021
Q3 | $1K | Hold |
48
| – | – | ﹤0.01% | 1281 |
|
|
2021
Q2 | $1K | Hold |
48
| – | – | ﹤0.01% | 1212 |
|
|
2021
Q1 | $1K | Hold |
48
| – | – | ﹤0.01% | 1226 |
|
|
2020
Q4 | $1K | Sell |
48
-70
| -59% | -$1.46K | ﹤0.01% | 1205 |
|
|
2020
Q3 | $2K | Hold |
118
| – | – | ﹤0.01% | 1136 |
|
|
2020
Q2 | $32K | Hold |
118
| – | – | ﹤0.01% | 970 |
|
|
2020
Q1 | $2K | Hold |
118
| – | – | ﹤0.01% | 1155 |
|
|
2019
Q4 | $3K | Sell |
118
-15
| -11% | -$381 | ﹤0.01% | 1137 |
|
|
2019
Q3 | $3K | Sell |
133
-17
| -11% | -$383 | ﹤0.01% | 1096 |
|
|
2019
Q2 | $5K | Hold |
150
| – | – | ﹤0.01% | 1087 |
|
|
2019
Q1 | $6K | Buy |
+150
| New | +$6K | ﹤0.01% | 1059 |
|